首都食品与医药
首都食品與醫藥
수도식품여의약
Capital Medicine
2015年
16期
71-72
,共2页
黄杨宁%心律失常%临床应用效果
黃楊寧%心律失常%臨床應用效果
황양저%심률실상%림상응용효과
Huangyangning%Arrhythmias%clinical results
目的:观察分析黄杨宁治疗心律失常的临床应用效果。方法随机选取2012年1月1日~2013年1月1日期间我院的60例心律失常患者,随机分为对照组(30例)和试验组(30例)。给予对照组患者心律平治疗,在对照组的治疗基础上,给予试验组患者黄杨宁抗心律失常治疗,观察、比较两组患者的治疗结果。结果试验组的总有效率(90.00%)高于对照组的总有效率(60.00%),试验组的并发症发生率(6.67%)低于对照组的并发症发生率(33.33%),P<0.05,具有统计学意义。结论黄杨宁治疗心律失常的临床应用效果好,副作用少,可考虑于心律失常的治疗中推广应用。
目的:觀察分析黃楊寧治療心律失常的臨床應用效果。方法隨機選取2012年1月1日~2013年1月1日期間我院的60例心律失常患者,隨機分為對照組(30例)和試驗組(30例)。給予對照組患者心律平治療,在對照組的治療基礎上,給予試驗組患者黃楊寧抗心律失常治療,觀察、比較兩組患者的治療結果。結果試驗組的總有效率(90.00%)高于對照組的總有效率(60.00%),試驗組的併髮癥髮生率(6.67%)低于對照組的併髮癥髮生率(33.33%),P<0.05,具有統計學意義。結論黃楊寧治療心律失常的臨床應用效果好,副作用少,可攷慮于心律失常的治療中推廣應用。
목적:관찰분석황양저치료심률실상적림상응용효과。방법수궤선취2012년1월1일~2013년1월1일기간아원적60례심률실상환자,수궤분위대조조(30례)화시험조(30례)。급여대조조환자심률평치료,재대조조적치료기출상,급여시험조환자황양저항심률실상치료,관찰、비교량조환자적치료결과。결과시험조적총유효솔(90.00%)고우대조조적총유효솔(60.00%),시험조적병발증발생솔(6.67%)저우대조조적병발증발생솔(33.33%),P<0.05,구유통계학의의。결론황양저치료심률실상적림상응용효과호,부작용소,가고필우심률실상적치료중추엄응용。
Objective To observe and analyze the clinical effect of Huangyangning in treatment of arrhythmia.Methods Randomly selected 60 cases of arrhythmia in our hospital between the date of January 1, 2012 to 1 January 2013, patients were randomly divided into a control group (30 cases) and the experimental group (30 cases). Patients in the control group were given to propafenone treatment, on the basis of the control group treatment, the experimental group of patients were given Huangyangning antiarrhythmic treatment, observation and comparison of treatment outcome between the two groups of patients.Results The total effective rate of the test group (90.00%) was higher (60.00%) than the total efficiency of the control group, test group of complication rate (6.67%) was lower than the control group of complication rate (33.33%),P ﹤0.05, there was statistically significant.Conclusion The clinical effect of Huangyangning in treatment of arrhythmia is better, has less side effects, it may be considered in the application in the treatment of cardiac arrhythmias.